Lsk is a protein tyrosine kinase with homology to the COOH-terminal Src kinase (Csk). Unlike Csk that is ubiquitously expressed, Lsk has limited tissue distribution. Here we have examined the expression and regulation of Lsk and Csk in peripheral human monocytes. We have found that Lsk mRNA and protein were not expressed in resting monocytes but were induced by treatment with interleukin 4 (IL-4) or IL-13 but not by interferon gamma (IFN-gamma) or IL-2. In fact, IFN-gamma, but not IL-2, efficiently blocked Lsk induction by IL-4 or IL-13. In contrast, Csk was constitutively present in human monocytes and was upregulated by IFN-gamma but not by IL-4 or IL-13. These results suggest that despite their structural similarities, Lsk and Csk may play distinct regulatory roles in monocyte functions elicited by cytokines, with Lsk functioning specifically within the context of a Th2-type immune response.
Skip Nav Destination
Article navigation
1 December 1994
Article|
December 01 1994
IL-4 and IL-13 induce Lsk, a Csk-like tyrosine kinase, in human monocytes.
T Musso,
T Musso
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp., National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201.
Search for other works by this author on:
L Varesio,
L Varesio
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp., National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201.
Search for other works by this author on:
X Zhang,
X Zhang
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp., National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201.
Search for other works by this author on:
T K Rowe,
T K Rowe
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp., National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201.
Search for other works by this author on:
P Ferrara,
P Ferrara
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp., National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201.
Search for other works by this author on:
J R Ortaldo,
J R Ortaldo
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp., National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201.
Search for other works by this author on:
J J O'Shea,
J J O'Shea
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp., National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201.
Search for other works by this author on:
D W McVicar
D W McVicar
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp., National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201.
Search for other works by this author on:
T Musso
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp., National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201.
L Varesio
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp., National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201.
X Zhang
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp., National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201.
T K Rowe
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp., National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201.
P Ferrara
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp., National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201.
J R Ortaldo
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp., National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201.
J J O'Shea
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp., National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201.
D W McVicar
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp., National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1994) 180 (6): 2383–2388.
Citation
T Musso, L Varesio, X Zhang, T K Rowe, P Ferrara, J R Ortaldo, J J O'Shea, D W McVicar; IL-4 and IL-13 induce Lsk, a Csk-like tyrosine kinase, in human monocytes.. J Exp Med 1 December 1994; 180 (6): 2383–2388. doi: https://doi.org/10.1084/jem.180.6.2383
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement